NASDAQ:CTMX

Cytomx Therapeutics Stock Predictions

etoro logo Buy CTMX
*Your capital is at risk
$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CTMX Prediction Chart

CTMX Predictions History

Latest community submissions for CTMX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 24, 2026 Bullish $4.24 X 0
Mar 17, 2026 $6.51 -3.49% $5.45 V 80.47% 1
Mar 17, 2026 $6.60 -2.18% $5.45 V 78.85% 1
Skagitqg Skagitqg Merchant
Mar 17, 2026 Bullish $5.45 V 0
Mar 10, 2026 $4.88 -3.08% $4.88 V 99.90% 10
Mar 10, 2026 $5.13 +1.92% $4.88 X 94.94% 0
Skagitqg Skagitqg Merchant
Mar 10, 2026 Bearish $4.88 X 1
Jan 23, 2026 $5.56 -2.82% $5.55 V 99.84% 6
Jan 23, 2026 $5.62 -1.76% $5.55 V 98.75% 2
Skagitqg Skagitqg Merchant
Jan 23, 2026 Bullish $5.55 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CTMX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CYTOMX THERAPEUTICS
CytomX Therapeutics
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE